Gram-Positive Bacterial Infections
Conditions
Keywords
Vancomycin, Pharmacokinetics, Trough level, Pediatric
Brief summary
In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine.
Detailed description
In this retrospective registry the investigators wish to verify whether the current dosing regime of vancomycin is leading to the appropriate pharmacokinetic targets in pediatric patients. Therefore data will be collected from all pediatric patients hospitalized in University Hospitals Leuven between January 2012 and April 2014 who were treated with vancomycine. Patient files will be screened for relevant information. Individual patients can be included multiple times if vancomycin has been administered more than once.
Interventions
OTHERPlasma exposure vancomycin
Investigation of plasma exposure of vancomycin.
Sponsors
Universitaire Ziekenhuizen KU Leuven
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Pediatric patients hospitalized in the University Hospitals Leuven between January 2012 and April 2014, treated with vancomycin
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Loading dose related plasma exposure vancomycin | 24 hours after loading dose | Plasma exposure to vancomycin in relation to administered dose |
Other
| Measure | Time frame | Description |
|---|---|---|
| Loading dose related plasma exposure vancomycin | 24 hours after dosage adjustment | Plasma exposure to vancomycin in relation to administered dose |
Countries
Belgium
Outcome results
None listed